DUBLIN, Ireland, March 25, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced today…
Novavax Shares Spike After Successful Late-Stage NanoFlu Vaccine Trial
Gaithersburg, Maryland-based Novavax announced positive topline data from its pivotal Phase III clinical trial of NanoFlu, its seasonal flu vaccine. The primary objectives were non-inferior immunogenicity of NanoFlu compared to Sanofi’s Fluzone Quadrivalent based on several 28-day metrics. Company shares…
Gilead halts ‘compassionate use’ of potential coronavirus drug
Gilead has said it has stopped accepting “compassionate use” requests for its potential coronavirus antiviral remdesivir because it cannot keep pace with demand as health systems become overwhelmed. Remdesivir is seen as the best hope in the fight against the…
Pharma steps up as coronavirus cases soar to 400,000-plus
With the coronavirus pandemic gathering momentum outside China, AstraZeneca has said it will donate 9 million face masks to healthcare workers around the world. The first shipments of the face masks are already en route to Italy, according to AZ,…
Celltrion to develop coronavirus antibody and fast test
South Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working on an antibody-based antiviral and a self-testing diagnosis kit providing results within 15-20 minutes. Best known as a manufacturer of biosimilars –…
Roche Launches Phase III Study of Rheumatoid Arthritis Drug for COVID-19 Pneumonia
Days after Swiss pharma giant Roche began shipping hundreds of thousands of its recently-approved COVID-19 test to laboratories in the United States, the company has initiated a late-stage trial assessing its rheumatoid arthritis drug Actemra in patients who have severe…
Pfizer Posts Positive Results in Two Phase III Studies, Postpones Investor Day
Pfizer had a good day Wednesday with the announcement of positive results from two Phase III trials, one in moderate to severe atopic dermatitis and one in pneumococcal disease. In pneumococcal disease, Pfizer announced top-line results from a late-stage study…
BioXcel Therapeutics Provides an Update on its Ongoing Phase 3 SERENITY Trials
More than one-third of the SERENITY I & II patients have been dosed, including over 100 bipolar patients On track to report topline data from both studies in mid-2020 NEW HAVEN, Conn., March 19, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics,…
DePuy announces CE mark for dual mobility system for hips
Johnson & Johnson has announced that DePuy Synthes, which produces cementless hip implants, has been informed of the European CE mark on its new Bi-Mentum Dual Mobility System for use in patients with a higher risk of dislocation. Bi-Mentum features a standard…
Market for 5G in manufacturing expected to reach $10.8bn by 2030
The market for 5G cellular connections in manufacturing is expected to reach $10.8 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 187%, according to global tech market advisory firm, ABI Research. The current Industry 4.0 digitalisation discourse…
